Compare Unichem Lab with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CADILA HEALTHCARE UNICHEM LAB/
CADILA HEALTHCARE
 
P/E (TTM) x -104.2 19.7 - View Chart
P/BV x 0.6 2.6 21.7% View Chart
Dividend Yield % 2.4 1.3 184.7%  

Financials

 UNICHEM LAB   CADILA HEALTHCARE
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
CADILA HEALTHCARE
Mar-19
UNICHEM LAB/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs292432 67.5%   
Low Rs182306 59.4%   
Sales per share (Unadj.) Rs167.7128.6 130.4%  
Earnings per share (Unadj.) Rs-3.618.5 -19.6%  
Cash flow per share (Unadj.) Rs5.924.4 24.4%  
Dividends per share (Unadj.) Rs4.003.50 114.3%  
Dividend yield (eoy) %1.70.9 178.1%  
Book value per share (Unadj.) Rs372.3101.5 366.9%  
Shares outstanding (eoy) m70.381,023.74 6.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.42.9 49.2%   
Avg P/E ratio x-65.319.9 -327.7%  
P/CF ratio (eoy) x39.915.1 263.4%  
Price / Book Value ratio x0.63.6 17.5%  
Dividend payout %-110.218.9 -583.8%   
Avg Mkt Cap Rs m16,680378,170 4.4%   
No. of employees `0002.612.4 20.9%   
Total wages/salary Rs m2,39321,241 11.3%   
Avg. sales/employee Rs Th4,535.210,585.0 42.8%   
Avg. wages/employee Rs Th919.81,707.8 53.9%   
Avg. net profit/employee Rs Th-98.21,526.5 -6.4%   
INCOME DATA
Net Sales Rs m11,801131,656 9.0%  
Other income Rs m9842,011 48.9%   
Total revenues Rs m12,785133,667 9.6%   
Gross profit Rs m-83529,731 -2.8%  
Depreciation Rs m6745,986 11.3%   
Interest Rs m751,935 3.9%   
Profit before tax Rs m-60023,821 -2.5%   
Minority Interest Rs m0469 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3435,303 -6.5%   
Profit after tax Rs m-25618,987 -1.3%  
Gross profit margin %-7.122.6 -31.3%  
Effective tax rate %57.322.3 257.3%   
Net profit margin %-2.214.4 -15.0%  
BALANCE SHEET DATA
Current assets Rs m20,38484,981 24.0%   
Current liabilities Rs m5,02973,425 6.8%   
Net working cap to sales %130.18.8 1,482.5%  
Current ratio x4.11.2 350.2%  
Inventory Days Days10575 140.6%  
Debtors Days Days135110 123.1%  
Net fixed assets Rs m9,023133,493 6.8%   
Share capital Rs m1411,024 13.8%   
"Free" reserves Rs m26,058102,839 25.3%   
Net worth Rs m26,199103,863 25.2%   
Long term debt Rs m039,497 0.0%   
Total assets Rs m31,496234,831 13.4%  
Interest coverage x-7.013.3 -52.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.40.6 66.8%   
Return on assets %-0.68.9 -6.4%  
Return on equity %-1.018.3 -5.3%  
Return on capital %-2.018.3 -10.9%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18848,404 16.9%   
Fx outflow Rs m59611,593 5.1%   
Net fx Rs m7,59236,811 20.6%   
CASH FLOW
From Operations Rs m-3,27828,823 -11.4%  
From Investments Rs m-2,860-57,387 5.0%  
From Financial Activity Rs m-2418,846 -0.1%  
Net Cashflow Rs m-4,690-7,105 66.0%  

Share Holding

Indian Promoters % 50.1 74.8 67.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 8.3 181.9%  
FIIs % 3.0 5.9 50.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 11.0 288.2%  
Shareholders   20,176 44,069 45.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ELDER PHARMA  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 416 Points Lower; Banking and Energy Stocks Witness Huge Selling(Closing)

After hitting record highs in the morning trade today, India share markets gave up all the gains and ended near day's low with Nifty below 12,250 level.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 20, 2020 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS